Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients.
Einecke
G
G
Department of Nephrology, Humboldt University, Berlin, Germany.
Mai
I
I
Diekmann
F
F
Fritsche
L
L
Boehler
T
T
Neumayer
H H
HH
Budde
K
K
D000284:Administration, Oral; D016572:Cyclosporine / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007408:Intestinal Absorption; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D015203:Reproducibility of Results; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine